Status: Not yet recruiting
A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
The primary purpose of the study is to evaluate the safety and efficacy of 2 doses of AC01 compared to placebo over 12 weeks in participants with chronic advanced HFrEF.
Participants needed: 400
Trial details
Phase: Phase 2Age: 18-85Biological sex: AllType: InterventionalSponsor: AnaCardio ABUpdated: Jun 15, 2026
Eligibility criteria
History of Chronic Heart Failure (CHF) diagnosed greater than or equal to (>=6)... [+7]
Any acute or serious co-morbid condition that could lead to premature terminatio... [+18]